Sex disparities in cystic fibrosis in the era of highly effective modulator treatment. [PDF]
McNally E, Casey M.
europepmc +1 more source
Effects of an artificial diet on growth of patients with cystic fibrosis.
J Yassa, R Prosser, J.A. Dodge
openalex +1 more source
Elexacaftor/Tezacaftor/Ivacaftor Population Pharmacokinetics in Pediatric Patients With Cystic Fibrosis. [PDF]
Truong NH+31 more
europepmc +1 more source
Low Th17 cells in patients with cystic fibrosis and allergic broncho-pulmonary aspergillosis. [PDF]
Timpano S+12 more
europepmc +1 more source
Cystic fibrosis therapy: from symptoms to the cause of the disease. [PDF]
Kireeva TN, Zhigalina DI, Skryabin NA.
europepmc +1 more source
Effect of cystic fibrosis modulator therapies on serum levels of fat-soluble vitamins. [PDF]
Crehuá-Gaudiza E+23 more
europepmc +1 more source
Insights on the Pathogenesis of <i>Mycobacterium abscessus</i> Infection in Patients with Cystic Fibrosis. [PDF]
Basher M, Gur M, Meir M.
europepmc +1 more source
ENaC is a host susceptibility factor to bacterial infections in cystic fibrosis context. [PDF]
Touré H+7 more
europepmc +1 more source
Cystic fibrosis-related bone disease: an update on screening, diagnosis, and treatment. [PDF]
Cobb C, Wu M, Tangpricha V.
europepmc +1 more source